Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Wang, Hualei ^a,b,c   Zhang, Guoqing ^a   Wen, Yongjun ^a   Yang, Songtao ^b   Xia, Xianzhu ^b   Fu, Zhen F ^a,d  

^a UNIVERSITY OF GEORGIA   (United States)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c JILIN UNIVERSITY   (China)

^d HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; RABIES VACCINE; CHEMOKINE; RECOMBINANT DNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG EFFICACY; IMMUNIZATION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; TREATMENT OUTCOME; ANIMAL; B LYMPHOCYTE; BRAIN; DENDRITIC CELL; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOGENICITY; PERMEABILITY; TIME; ULTRAVIOLET RADIATION; VIROLOGY;

ANIMALIA; MUS; RABIES VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; BRAIN; CHEMOKINE CCL2; CHEMOKINES; DENDRITIC CELLS; DNA, RECOMBINANT; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY, INNATE; MICE; NEUTROPHIL INFILTRATION; PERMEABILITY; RABIES; RABIES VIRUS; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 80053226446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025414     Document Type: Article

References (43)

1. Meslin FX, Fishbein DB, Matter HC, (1994) Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol 187: 1-26.
2. Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, et al. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83: 360-368.
3. Fu ZF, (1997) Rabies and rabies research: past, present and future. Vaccine 15 Supplpp. S20-24.
4. Lackay SN, Kuang Y, Fu ZF, (2008) Rabies in small animals. Vet Clin North Am Small Anim Pract 38: 851-861 ix.
5. Nigg AJ, Walker PL, (2009) Overview, prevention, and treatment of rabies. Pharmacotherapy 29: 1182-1195.
6. Blanton JD, Palmer D, Rupprecht CE, (2010) Rabies surveillance in the United States during 2009. J Am Vet Med Assoc 237: 646-657.
7. Hattwick MA, Hochberg FH, Landrigan PJ, Gregg MB, (1972) Skunk-associated human rabies. JAMA 222: 44-47.
8. CDC, (2003) First human death associated with raccoon rabies-Virginia, 2003. MMWR Morb Mortal Wkly Rep 52: 1102-1103.
9. Rupprecht CE, Smith JS, Krebs JW, Childs JE, (1997) Molecular epidemiology of rabies in the United States: reemergence of a classical neurotropic agent. J Neurovirol 3 (Suppl 1): S52-53.
10. Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, et al. (1996) Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America. Proc Natl Acad Sci U S A 93: 5653-5658.
11. WHO (2010) Fact Sheet No 99.
12. Rupprecht CE, Hanlon CA, Hemachudha T, (2002) Rabies re-examined. Lancet Infect Dis 2: 327-343.
13. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, et al. (2005) Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79: 12554-12565.
14. Zhao L, Toriumi H, Kuang Y, Chen H, Fu ZF, (2009) The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J Virol 83: 11808-11818.
15. Zhao L, Toriumi H, Wang H, Kuang Y, Guo X, et al. (2010) Expression of MIP-1{alpha} (CCL3) by a Recombinant Rabies Virus Enhances Its Immunogenicity by Inducing Innate Immunity and Recruiting Dendritic Cells and B Cells. J Virol 84: 9642-9648.
16. Wen Y, Wang H, Wu H, Yang F, Tripp RA, et al. (2011) Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol 85: 1634-1644.
17. Kuang Y, Lackay SN, Zhao L, Fu ZF, (2009) Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144: 18-26.
18. Roy A, Phares TW, Koprowski H, Hooper DC, (2007) Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 81: 1110-1118.
19. Roy A, Hooper DC, (2007) Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 81: 7993-7998.
20. Smith JS, Yager, A P, Baer, M G, (1996) A rapid fluorescence focus inhibition test (RFFIT) for determining rabies virus-neutralisng antibody. In: Meslin F-X, Kaplan MM, Koprowski H, editors. Laboratory Techniques in Rabies, 4th ed 181-192.
21. Barker CF, Billingham RE, (1977) Immunologically privileged sites. Adv Immunol 25: 1-54.
22. Hosking MP, Lane TE, (2010) The role of chemokines during viral infection of the CNS. PLoS Pathog 6: e1000937.
23. Kim JV, Kang SS, Dustin ML, McGavern DB, (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457: 191-195.
24. Phares TW, Fabis MJ, Brimer CM, Kean RB, Hooper DC, (2007) A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol 178: 7334-7343.
25. Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, et al. (2009) Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A 106: 11300-11305.
26. Merrill JE, Murphy SP, (1997) Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain Behav Immun 11: 245-263.
27. Stanimirovic D, Satoh K, (2000) Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 10: 113-126.
28. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, et al. (2005) Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25: 593-606.
29. Prehaud C, Megret F, Lafage M, Lafon M, (2005) Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J Virol 79: 12893-12904.
30. Johnson N, McKimmie CS, Mansfield KL, Wakeley PR, Brookes SM, et al. (2006) Lyssavirus infection activates interferon gene expression in the brain. J Gen Virol 87: 2663-2667.
31. Sarmento L, Li XQ, Howerth E, Jackson AC, Fu ZF, (2005) Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice. J Neurovirol 11: 571-581.
32. Hemachudha T, Phanuphak P, Sriwanthana B, Manutsathit S, Phanthumchinda K, et al. (1988) Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients. Am J Med 84: 673-677.
33. Hooper DC, Phares TW, Fabis MJ, Roy A, (2009) The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis 3: e535.
34. Sudarshan MK, Madhusudana SN, Mahendra BJ, (1999) Post-exposure prophylaxis with purified vero cell rabies vaccine during pregnancy-safety and immunogenicity. J Commun Dis 31: 229-236.
35. Sampath G, Parikh S, Sangram P, Briggs DJ, (2005) Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine 23: 1102-1105.
36. Dietzschold B, Hooper DC, (1998) Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV). Vaccine 16: 1656-1659.
37. Brochier B, Kieny MP, Costy F, Coppens P, Bauduin B, et al. (1991) Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 354: 520-522.
38. Hanlon CA, Niezgoda M, Hamir AN, Schumacher C, Koprowski H, et al. (1998) First North American field release of a vaccinia-rabies glycoprotein recombinant virus. J Wildl Dis 34: 228-239.
39. Schumacher CL, Coulon P, Lafay F, Benejean J, Aubert MF, et al. (1993) SAG-2 oral rabies vaccine. Onderstepoort J Vet Res 60: 459-462.
40. Wu X, Franka R, Henderson H, Rupprecht CE, (2011) Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies. Vaccine 29: 4195-4201.
41. Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprecht CE, et al. (2000) Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J Hum Virol 3: 50-57.
42. Li XQ, Sarmento L, Fu ZF, (2005) Degeneration of neuronal processes after infection with pathogenic, but not attenuated, rabies viruses. J Virol 79: 10063-10068.
43. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent end points. Am J Hyg pp. 493-497.